Insights & News

Stradley Ronon Acquires Patrick J. Kelly to Expand its Life Sciences Practice

October 31, 2019
Firm News
PHILADELPHIA – Stradley Ronon is pleased to announce that Patrick J. Kelly, Ph.D., has joined the Malvern office as Counsel in the intellectual property group.

“We are thrilled to welcome Patrick as he brings an extraordinary wealth of knowledge about and insight into the business of life sciences to the firm,” said Kevin R. Casey, Stradley Ronon’s intellectual property chair. “His background and approach to intellectual property matters is what makes him an invaluable resource as we expand our group’s depth.”

For more than 20 years, Kelly has focused his practice on intellectual property matters within the life sciences industry. He has experience serving as an advisor to pharmaceutical, biotech and scientific instrumentation companies in all aspects of patent law, including preparing and prosecuting patent applications, formulating and maintaining biotech intellectual property estates, due diligence, freedom-to-operate studies and licensing. 

Kelly began his career as an academic scientist at the Georgia Institute of Technology where he earned his Ph.D. in molecular biology. He has expertise in biochemistry, immunology, virology, proteomics, genomics, transgenic animals, gene therapy and drug delivery systems.

Before joining Stradley Ronon, Kelly was a partner in patent and general practice law firms and served as an advisor to start-up programs and medical technology incubators.

Kelly earned his J.D. from Temple University Beasley School of Law and his B.S. from Georgetown University.

About Stradley Ronon
Counseling clients since 1926, Stradley Ronon has helped private and public companies – from small businesses to Fortune 500 corporations – achieve their goals by providing pragmatic, value-driven legal counsel. With offices in eight strategic locations, our responsive team of more than 200 attorneys seamlessly addresses the full spectrum of our clients’ needs, ranging from sophisticated corporate transactions to complex commercial litigation.

Related Resources

back to top